Company NeoPharm CO., LTD.

Company NeoPharm CO., LTD.

A092730

KR7092730001

Personal Products

Equities

A092730

KR7092730001

Personal Products

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Ratings for NeoPharm CO., LTD.

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Cosmetics & Perfumes

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Ratings for NeoPharm CO., LTD.

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Cosmetics & Perfumes

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
28,400 ^KRW	+3.27%		+5.38%	+9.86%

2023	NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2019	NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding	CI

NeoPharm Co., Ltd. is a Korea-based company engaged in the manufacture of cosmetics. The Company produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. It also engages in the original equipment manufacturing (OEM) of skin drugs.

Number of employees: 142

KRW in Million	2022	Weight	2023	Weight	Delta
Cosmetics Product 99.1 %	83,887	99.6 %	96,272	99.1 %	+14.76%
Cosmetics Merchandise 0.7 %	208	0.2 %	677	0.7 %	+225.43%
Other 0.2 %	118	0.1 %	156	0.2 %	+32.23%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	84,212	100.0 %	97,105	100.0 %	+15.31%

Managers	Title	Age	Since
Yang-Soo Kim CEO	Chief Executive Officer	54	12-07-31
Yoon Kim CTO	Chief Tech/Sci/R&D Officer	59	00-06-30
Woo-Jae Lim BRD	Director/Board Member	45	21-03-24
Byeong-Cheol Im PRN	Corporate Officer/Principal	65	16-12-31

Members of the board	Title	Age	Since
Yoon Kim CTO	Chief Tech/Sci/R&D Officer	59	00-06-30
Dong-Jin Choi BRD	Director/Board Member	64	19-03-20
Yang-Soo Kim CEO	Chief Executive Officer	54	12-07-31
Woo-Jae Lim BRD	Director/Board Member	45	21-03-24
Hak-Young Kim BRD	Director/Board Member	72	19-03-20
Gi-Young Hong BRD	Director/Board Member	68	19-03-20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	8,207,361	4,674,864 ( 56.96 %)	386,733 ( 4.712 %)	56.96 %

Name	Equities	%	Valuation
IT'S HANBUL CO., LTD. 37.23 %	3,055,264	37.23 %	57 M ₩
NEOPHARM CO., LTD. 4.712 %	386,733	4.712 %	7 M ₩
Byeong-Cheol Im 1.097 %	90,000	1.097 %	2 M ₩
Dimensional Fund Advisors Ltd. 0.0456 %	3,744	0.0456 %	70 432 ₩
Russell Investments Ltd. 0.0355 %	2,910	0.0355 %	54 743 ₩
Mirae Asset Global Investments Co., Ltd. 0.0347 %	2,851	0.0347 %	53 633 ₩
Niche Asset Management Ltd. 0.0207 %	1,700	0.0207 %	31 980 ₩
DFA Australia Ltd. 0.004752 %	390	0.004752 %	7 337 ₩

Name	Equities	%	Valuation
NEOPHARM CO., LTD. 4.71%	386,733	4.71%	7,275,202 $

NeoPharm Co., Ltd.

309-8 Techno 2-ro Yuseong-gu

34037, Daejeon

http://www.neopharm.co.kr

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

	1st Jan change	Capi.
NEOPHARM CO., LTD.	+9.86%	163M
L'ORÉAL	-2.27%	259B
KAO CORPORATION	+18.81%	20.66B
GALDERMA GROUP AG	0.00%	19.04B
SHISEIDO COMPANY, LIMITED	+17.33%	12.68B
COTY INC.	-13.77%	9.25B
AMOREPACIFIC CORPORATION	+23.03%	8.07B
PROYA COSMETICS CO.,LTD.	+11.07%	6.01B
NATURA &CO HOLDING S.A.	-12.20%	3.98B
INTER PARFUMS, INC.	-16.08%	3.87B

Cosmetics & Perfumes

Consumer Non-Cyclicals

Personal & Household Products & Services

Personal &Household Products & Services

Personal Products

Cosmetics & Perfumes